Buy Rating Justified by Arcturus Therapeutics’ Market Potential and Strong Vaccine Efficacy
H.C. Wainwright analyst Ed Arce maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report) today and set a price target of ...
ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
Arcturus stock gains as the company reports that its sa-mRNA COVID-19 vaccine, ARCT-154, shows superior efficacy compared ...
The Delaware Gazette3h
Spectacular comet could be visible mid-October
There’s a comet in the sky with the potential to become naked-eye visible in mid-October. Comet C/2023 A3 Tsuchinshan-ATLAS ...
Euro Weekly News20h
How to view T Coronae Borealis: A spectacular celestial event
Coronae Borealis, a star located 3,000 light-years from Earth, is said to be preparing for a dramatic explosion that hasn’t ...
Camp4 Therapeutics Targets IPO On Early Positive Results
Camp4 Therapeutics is seeking $75 million in its IPO to advance clinical-stage programs. Learn more about CAMP stock and ...
PipelineReview.com21h
Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination
Head-to-head data, presented at OPTIONS XII for the Control of Influenza Conference, demonstrates advantage of sa-mRNA over conventional mRNA in duration of ...
renonr20h
October skies: The month brings a potentially bright comet—and the possible eruption of a nova!
The comet will pass closest to Earth on Oct. 12, at a distance of 43.9 million miles. The comet is visible in the mornings, rising in twilight 7-8° south of east, just more than an hour before sunrise ...